Survival of dogs administered 9.2 Gy TBI followed by hematopoietic grafts from DLA-nonidentical donors. Dogs were administered either no immunosuppression, MMF alone, CSP alone, MTX+CSP, or MMF+CSP. For details on the immunosuppressive regimens, see Tables 1 and 4.